Shionogi snatches Victory portfolio from jaws of past defeat
This article was originally published in Scrip
Executive Summary
Shionogi's US subsidiary has agreed to acquire the entire marketed portfolio of the private US firm Victory Pharma in a move that will bolster its commercial presence in pain and infection.